Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases
A global landscape study of funding trends and innovations
White Paper
Sep 06, 2019

The cost of cancer and high-cost chronic noncommunicable diseases (NCDs) are significant and growing, posing an increasingly high burden of disease to health systems, businesses and individuals. Optimal patient outcomes are fundamentally linked to affordability and, despite meaningful efforts within the health system, current traditional funding models will struggle to close the funding gap.

This global landscape study identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia, Europe, Latin America and Middle East. The study aims to enable readers to better understand the possibilities of innovative funding while stressing the key success factors that enable sustainability and success, such as stakeholder collaboration.

Global landscape

Globally, noncommunicable diseases (NCDs) are rising in prevalence, particularly in low and middle income countries (LMICs). NCDs can be categorized into cardiovascular diseases, diabetes, respiratory diseases and cancers.

Management of NCDs requires long term and ongoing therapy, and in the case of cancer—expensive interventions, posing an increasingly high burden of disease to achieve optimal patient outcomes.

Particularly in LMICs, lack of sufficient funding often leaves patients with the choice between abandoning treatment or facing financial hardship. Despite meaningful efforts within the health system, current traditional funding models will struggle to close the gap.

Innovative funding models

Innovative funding models can be leveraged as part of the solution to address these challenges through new means of raising funds and providing alternative financing delivery options. In collaboration, Roche and IQVIA conducted an in-depth analysis of innovative funding models in a global landscape study compromised of:

  • Coverage of 5 regions around the world (Africa, Asia, Europe, Latin America, Middle East) as well as highlighted cases from 17 countries.
  • Identification of 105 innovative funding models, from research analysis supported by 32 expert interviews from government, NGO and industry sector.
  • 36 showcased examples to enable readers to better understand different possibilities for innovative funding models. Models were found to focus on unlocking new funds, pooling resources or to target distribution and delivery of said funds –or a combination


Download to read more

Bring innovations in oncology treatments to patients, faster

Patient Engagement

Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.

Oncology Data Network

The Collaboration for Oncology Data in Europe (CODE) seeks to expand our knowledge of anti-cancer medicine use through a dedicated oncology data network.

You may also be interested in
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.